CS Diagnostics Corp (FZRO)

[MU_Redskin1]

Reverse split coming ... then forward split to reduce the outstanding share count!

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
The majority control stock of the Company was acquired by CS Diagnostics on March 30, 2022. On March 31, 2022, the Common Shares are transferred to 15,000,000 CS InterPharm General Trading, a Dubai, United Arab Emirates company; 60,352,000 CS Diagnostics GmbH, a German Company; 20,000,000 Euro Gus Group, a Czech Company and 15,000,000 Le Pharm , a German Company. The 10 shares of Preferred Series A were transferred to CS Diagnostics GmbH, a German Company and the 9,989,000 Preferred Series B shares were transferred to CS Diagnostics GmbH, a German Company.
On May 1st, 2022, the Board of Directors and the majority shareholders have approved (1) an Amendment to the Articles of Incorporation to “The Name of the Company is CS Diagnostics Corp.”; (2) A 1 to 100,000 Reverse Stock Split with a 1 to 200 Forward Stock Split to provide the minimum number of shares for the lowest shareholder shall be 200 shares; and (3) Application to FINRA for approval of the Name Change, Stock Symbol Cusip Number and approval of the stock split as soon as practical.
The address(es) of the Issuer’s principal place of business:
Check box if principal executive office and principal place of business are the same address: ?
Stresemannallee 4c Neuss 41460 Germany
[phone]

GLTA FZRO!

Cheers, Red